Biotronik launches Enitra 8 HF-T QP pacemaker in Europe.
Biotronik has launched its Enitra 8 HF-T-QP pacemaker in Europe after securing a CE Mark. A UK patient has become the first in Europe to be implanted with the streamlined device.The patient, a woman with a history of heart failure and complete heart block, had an Enitra 8 HF-T QP device implanted on July 27 at Great Western Hospital in Swindon, United Kingdom. The operation was a complete success and she is recovering well.
The E-Series has been gaining attention in the cardiac community because of the small size of the devices, their 14-year expected battery life, and the award-winning MRI AutoDetect sensor. This function detects when the device is in an MRI environment and automatically switches it to ProMRI mode. This limits the length of time a device remains in the limited functional state of ProMRI mode to the duration of the MRI scan only.